Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.
Methylphenidate (MPH), commercially called Ritalin or Concerta, has been widely used as a drug for Attention Deficit Hyperactivity Disorder (ADHD). Noteworthily, growing numbers of young people using prescribed MPH improperly for pleasurable enhancement, take high risk of addiction. Thus, understand...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284812/?tool=EBI |
| _version_ | 1818701730972434432 |
|---|---|
| author | Chun-Lei Zhang Ze-Jun Feng Yue Liu Xiao-Hua Ji Ji-Yun Peng Xue-Han Zhang Xue-Chu Zhen Bao-Ming Li |
| author_facet | Chun-Lei Zhang Ze-Jun Feng Yue Liu Xiao-Hua Ji Ji-Yun Peng Xue-Han Zhang Xue-Chu Zhen Bao-Ming Li |
| author_sort | Chun-Lei Zhang |
| collection | DOAJ |
| description | Methylphenidate (MPH), commercially called Ritalin or Concerta, has been widely used as a drug for Attention Deficit Hyperactivity Disorder (ADHD). Noteworthily, growing numbers of young people using prescribed MPH improperly for pleasurable enhancement, take high risk of addiction. Thus, understanding the mechanism underlying high level of MPH action in the brain becomes an important goal nowadays. As a blocker of catecholamine transporters, its therapeutic effect is explained as being due to proper modulation of D1 and α2A receptor. Here we showed that higher dose of MPH facilitates NMDA-receptor mediated synaptic transmission via a catecholamine-independent mechanism, in layer V∼VI pyramidal cells of the rat medial prefrontal cortex (PFC). To indicate its postsynaptic action, we next found that MPH facilitates NMDA-induced current and such facilitation could be blocked by σ1 but not D1/5 and α2 receptor antagonists. And this MPH eliciting enhancement of NMDA-receptor activity involves PLC, PKC and IP3 receptor mediated intracellular Ca(2+) increase, but does not require PKA and extracellular Ca(2+) influx. Our additional pharmacological studies confirmed that higher dose of MPH increases locomotor activity via interacting with σ1 receptor. Together, the present study demonstrates for the first time that MPH facilitates NMDA-receptor mediated synaptic transmission via σ1 receptor, and such facilitation requires PLC/IP3/PKC signaling pathway. This novel mechanism possibly explains the underlying mechanism for MPH induced addictive potential and other psychiatric side effects. |
| first_indexed | 2024-12-17T15:25:30Z |
| format | Article |
| id | doaj.art-af19d4ff4f3744079e968d9de70655b5 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-17T15:25:30Z |
| publishDate | 2012-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-af19d4ff4f3744079e968d9de70655b52022-12-21T21:43:17ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-01712e5191010.1371/journal.pone.0051910Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action.Chun-Lei ZhangZe-Jun FengYue LiuXiao-Hua JiJi-Yun PengXue-Han ZhangXue-Chu ZhenBao-Ming LiMethylphenidate (MPH), commercially called Ritalin or Concerta, has been widely used as a drug for Attention Deficit Hyperactivity Disorder (ADHD). Noteworthily, growing numbers of young people using prescribed MPH improperly for pleasurable enhancement, take high risk of addiction. Thus, understanding the mechanism underlying high level of MPH action in the brain becomes an important goal nowadays. As a blocker of catecholamine transporters, its therapeutic effect is explained as being due to proper modulation of D1 and α2A receptor. Here we showed that higher dose of MPH facilitates NMDA-receptor mediated synaptic transmission via a catecholamine-independent mechanism, in layer V∼VI pyramidal cells of the rat medial prefrontal cortex (PFC). To indicate its postsynaptic action, we next found that MPH facilitates NMDA-induced current and such facilitation could be blocked by σ1 but not D1/5 and α2 receptor antagonists. And this MPH eliciting enhancement of NMDA-receptor activity involves PLC, PKC and IP3 receptor mediated intracellular Ca(2+) increase, but does not require PKA and extracellular Ca(2+) influx. Our additional pharmacological studies confirmed that higher dose of MPH increases locomotor activity via interacting with σ1 receptor. Together, the present study demonstrates for the first time that MPH facilitates NMDA-receptor mediated synaptic transmission via σ1 receptor, and such facilitation requires PLC/IP3/PKC signaling pathway. This novel mechanism possibly explains the underlying mechanism for MPH induced addictive potential and other psychiatric side effects.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284812/?tool=EBI |
| spellingShingle | Chun-Lei Zhang Ze-Jun Feng Yue Liu Xiao-Hua Ji Ji-Yun Peng Xue-Han Zhang Xue-Chu Zhen Bao-Ming Li Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. PLoS ONE |
| title | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. |
| title_full | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. |
| title_fullStr | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. |
| title_full_unstemmed | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. |
| title_short | Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action. |
| title_sort | methylphenidate enhances nmda receptor response in medial prefrontal cortex via sigma 1 receptor a novel mechanism for methylphenidate action |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23284812/?tool=EBI |
| work_keys_str_mv | AT chunleizhang methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT zejunfeng methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT yueliu methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT xiaohuaji methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT jiyunpeng methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT xuehanzhang methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT xuechuzhen methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction AT baomingli methylphenidateenhancesnmdareceptorresponseinmedialprefrontalcortexviasigma1receptoranovelmechanismformethylphenidateaction |